References
- In Metabolic Inhibitors v.2 Hewitt, E. J;Nicholas, D. J. D;Hochester, R. M(ed.);Quastrel, J. H(eds.)
- Proc. Natl. Acad. Sci. USA v.79 Sternweis, P. C;Gilman, A. G
- FEBS Lett v.191 Bigay, J;Deterre, P;Pfister, C;Charbre, M
- EMBO J. v.6 Bigay, J;Deterre, P;Pfister, C;Charbre, M
- Biochemistry v.27 Carlier, M. F;Didry, D;Melki, R;Chabre, M;Casteels, T
- J. Biol. Chem. v.27 Combeau, C;Carlier, M. F
- J. Biol. Chem. v.261 Lange, A. J;Arion, W. J;Burchell, A;Burcjell, B
- Proc. Natl. Acad. Aci. USA v.85 Lunardi, J;Dupuis, A;Garin, J;Issartel, J. P;Michel, L;Chabre, M;Vignais, P. V
- Biochem. Biophys. Acta v.1140 Boyer, P. D
- Adv. Enzymol. v.64 Penefsky, H. S;Cross, R
- Biochim Biophys. Acta v.1319 Weber, J;Senior, A. E
- Nature v.370 Abrahams, J. P;Leslie, A. G. W;Lutter, R;Walker, J. E
- J. Biol. Chem. v.257 Cross, R. L;Nalin, C. M
- Physiol. Revs. v.68 Senior, A. E
- Biochemistry v.23 Perlin, D. S;Latchney, L. R;Wise, J. G;Senior, A. E
- Biochemical. J v.214 Wise, J. G;Duncan, T. M;Latchney, L. R;Cox, D. N;Senior, A. E
- FEBS Lett. v.255 Dupuis, A;Issartel, J. P;Vignais, P
- Biocheim. Biophys. Acta v.1015 Carr, M;Mulvey, D;Willis, A;Ferguson, S. J;Campbell, I. D
- J. Biochem. Mol. Biol v.31 Jung, S;Kim, H. W
- J. Biochem v.127 Lee, H. W;Sohn, J. H;Yeh, B. I;Choi, J. W;Jung, S;Kim, H. W
- Biochemical. J v.180 Senior, A. E;Falyle, D. R. H;Downie, J. A;Gibson, F;Cox, G. B
- Biochemistry v.19 Ting, L. P;Wang, J. J
- Anal. Biochem. v.72 Bradford, M. M
- J. Biol. Chem. v.256 Garett, N. E;Penefsky, H. S
- Bull. Korean Chem. Soc v.20 Sohn, J. H;Lee, H. W;Han, D. P;Yeh, B. I;Choi, J. W;Jung, S;Kim, H. W
- Biochemistry v.30 Isaartel, J. P;Dupuis, A;Unardi, J;Vignais, P. V
- FEBS Lett. v.278 Hazlett, T. L;Higashijima, T;Jameson, D. M
- J. Biol. Chem. v.266 Higashhijima, T;Graziano, M. P;Suga, H. S;Kaiosho, M;Gilman, A. G
- Nature v.387 Schindelin, H;Kisler, C;Schlessman, J. L;Howard, J. B;Rees, D. C
- Nature v.372 Sondek, J;Lambright, D. G;Noel, J. P;Hamm, H. E;Sigler, P. B
Cited by
- 19F NMR Investigation of F1-ATPase of Escherichia coli Using Fluoroberyllate Complex vol.29, pp.12, 2001, https://doi.org/10.5012/bkcs.2008.29.12.2499
- Observation of Asymmetry amongst Nucleotide Binding Sites of F1-ATPase of Escherichia coli by 31P NMR Spectroscopy vol.32, pp.2, 2001, https://doi.org/10.5012/bkcs.2011.32.2.531
- Conformational Changes of Nucleotide Binding Sites Following Sequential Addition of ADP to Nucleotide-depleted F1-ATPase of Escherichia coli Investigated with 31P NMR Spectroscop vol.32, pp.3, 2001, https://doi.org/10.5012/bkcs.2011.32.3.1051
- Conformational Changes of Nucleotide Binding Sites Following Sequential Addition of ADP to Nucleotide-depleted F1-ATPase of Escherichia coli Investigated with 31P NMR Spectroscop vol.32, pp.3, 2001, https://doi.org/10.5012/bkcs.2011.32.3.1051
- 31P NMR Spectroscopy Revealed Adenylate kinase-like Activity and Phosphotransferase-like Activity from F1-ATPase of Escherichia coli vol.32, pp.1, 2001, https://doi.org/10.5012/bkcs.2011.32.1.183
- Catalytic Sites of F1-ATPase from Escherichia coli was Investigated with GTP and GDP Titration Using 31P NMR Spectroscopy vol.33, pp.7, 2012, https://doi.org/10.5012/bkcs.2012.33.7.2419